Summer Savings! Get unlimited digital access for 13 weeks for $13.
Picture of Health
Health Picture of Health

Amgen to pay Maryland $856,000 in drug marketing case

Drug company Amgen Inc. will pay the Maryland Medicaid system $856,474 to settle allegations that it illegally marketed and priced drugs used to treat anemia, rheumatoid arthritis and other diseases.

The settlement, announced Friday by Maryland Attorney General Douglas F. Gansler, is part of a $612 million deal Illinois-based Amgen made with the federal government and several other states.

As part of the settlement, Amgen's future marketing practices will also be monitored by the federal government.

andrea.walker@baltsun.com

Twitter.com/ankwalker

Copyright © 2015, The Baltimore Sun
Related Content
Comments
Loading
88°